Low Oxygen Concentration Reduces Susceptibility to Resazurin

Overview

Journal Antibiotics (Basel)

Specialty Pharmacology

Date 2024 May 24

PMID 38786124

Authors

Justin Rice

Jordan Gibson

Emily Young

Kendall Souder

Kailee Cunningham

Deanna M Schmitt

Affiliations

Soon will be listed here.

Abstract

has developed resistance to every antibiotic currently approved for the treatment of gonorrhea, prompting the development of new therapies. The phenoxazine dye resazurin exhibits robust antimicrobial activity against in vitro but fails to limit vaginal colonization by in a mouse model. The lack of in vivo efficacy may be due to oxygen limitation as in vitro susceptibility assays with resazurin are conducted under atmospheric oxygen while a microaerophilic environment is present in the vagina. Here, we utilized broth microdilution assays to determine the susceptibility of to resazurin under low and atmospheric oxygen conditions. The minimal inhibitory concentration of resazurin for multiple clinical isolates was significantly higher under low oxygen. This effect was specific to resazurin as was equally susceptible to other antibiotics under low and atmospheric oxygen conditions. The reduced susceptibility of to resazurin under low oxygen was largely attributed to reduced oxidative stress, as the addition of antioxidants under atmospheric oxygen mimicked the reduced susceptibility to resazurin observed under low oxygen. Together, these data suggest oxygen concentration is an important factor to consider when evaluating the efficacy of new antibiotics against in vitro.

References

Wi T, Lahra M, Ndowa F, Bala M, Dillon J, Ramon-Pardo P . Antimicrobial resistance in Neisseria gonorrhoeae: Global surveillance and a call for international collaborative action. PLoS Med. 2017; 14(7):e1002344. PMC: 5501266. DOI: 10.1371/journal.pmed.1002344. View

Hagman K, Pan W, Spratt B, Balthazar J, JUDD R, Shafer W . Resistance of Neisseria gonorrhoeae to antimicrobial hydrophobic agents is modulated by the mtrRCDE efflux system. Microbiology (Reading). 1995; 141 ( Pt 3):611-22. DOI: 10.1099/13500872-141-3-611. View

St Cyr S, Barbee L, Workowski K, Bachmann L, Pham C, Schlanger K . Update to CDC's Treatment Guidelines for Gonococcal Infection, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69(50):1911-1916. PMC: 7745960. DOI: 10.15585/mmwr.mm6950a6. View

Dwyer D, Belenky P, Yang J, MacDonald I, Martell J, Takahashi N . Antibiotics induce redox-related physiological alterations as part of their lethality. Proc Natl Acad Sci U S A. 2014; 111(20):E2100-9. PMC: 4034191. DOI: 10.1073/pnas.1401876111. View

Unemo M, Shafer W . Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future. Ann N Y Acad Sci. 2012; 1230:E19-28. PMC: 4510988. DOI: 10.1111/j.1749-6632.2011.06215.x. View

Mickelsen P, Sparling P . Ability of Neisseria gonorrhoeae, Neisseria meningitidis, and commensal Neisseria species to obtain iron from transferrin and iron compounds. Infect Immun. 1981; 33(2):555-64. PMC: 350736. DOI: 10.1128/iai.33.2.555-564.1981. View

Unemo M, Lahra M, Escher M, Eremin S, Cole M, Galarza P . WHO global antimicrobial resistance surveillance for Neisseria gonorrhoeae 2017-18: a retrospective observational study. Lancet Microbe. 2022; 2(11):e627-e636. DOI: 10.1016/S2666-5247(21)00171-3. View

Zeitlinger M, Derendorf H, Mouton J, Cars O, Craig W, Andes D . Protein binding: do we ever learn?. Antimicrob Agents Chemother. 2011; 55(7):3067-74. PMC: 3122431. DOI: 10.1128/AAC.01433-10. View

Gould I . Towards a common susceptibility testing method?. J Antimicrob Chemother. 2000; 45(6):757-62. DOI: 10.1093/jac/45.6.757. View

10.

Hill S, Masters T, Wachter J . Gonorrhea - an evolving disease of the new millennium. Microb Cell. 2017; 3(9):371-389. PMC: 5354566. DOI: 10.15698/mic2016.09.524. View

11.

Kohanski M, Dwyer D, Collins J . How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol. 2010; 8(6):423-35. PMC: 2896384. DOI: 10.1038/nrmicro2333. View

12.

Gupta S, Laskar N, Kadouri D . Evaluating the Effect of Oxygen Concentrations on Antibiotic Sensitivity, Growth, and Biofilm Formation of Human Pathogens. Microbiol Insights. 2016; 9:37-46. PMC: 5113855. DOI: 10.4137/MBI.S40767. View

13.

Chitsaz M, Booth L, Blyth M, OMara M, Brown M . Multidrug Resistance in Neisseria gonorrhoeae: Identification of Functionally Important Residues in the MtrD Efflux Protein. mBio. 2019; 10(6). PMC: 6867893. DOI: 10.1128/mBio.02277-19. View

14.

Unemo M, Seifert H, Hook 3rd E, Hawkes S, Ndowa F, Dillon J . Gonorrhoea. Nat Rev Dis Primers. 2019; 5(1):79. DOI: 10.1038/s41572-019-0128-6. View

15.

Garvin L, Bash M, Keys C, Warner D, Ram S, Shafer W . Phenotypic and genotypic analyses of Neisseria gonorrhoeae isolates that express frequently recovered PorB PIA variable region types suggest that certain P1a porin sequences confer a selective advantage for urogenital tract infection. Infect Immun. 2008; 76(8):3700-9. PMC: 2493220. DOI: 10.1128/IAI.00265-08. View

16.

Rowley J, Vander Hoorn S, Korenromp E, Low N, Unemo M, Abu-Raddad L . Chlamydia, gonorrhoea, trichomoniasis and syphilis: global prevalence and incidence estimates, 2016. Bull World Health Organ. 2019; 97(8):548-562P. PMC: 6653813. DOI: 10.2471/BLT.18.228486. View

17.

Rymovicz A, Souza R, Gursky L, Rosa R, Trevilatto P, Groppo F . Screening of reducing agents for anaerobic growth of Candida albicans SC5314. J Microbiol Methods. 2011; 84(3):461-6. DOI: 10.1016/j.mimet.2011.01.020. View

18.

Jagannathan L, Cuddapah S, Costa M . Oxidative stress under ambient and physiological oxygen tension in tissue culture. Curr Pharmacol Rep. 2016; 2(2):64-72. PMC: 4809260. DOI: 10.1007/s40495-016-0050-5. View

19.

Tsevat D, Wiesenfeld H, Parks C, Peipert J . Sexually transmitted diseases and infertility. Am J Obstet Gynecol. 2016; 216(1):1-9. PMC: 5193130. DOI: 10.1016/j.ajog.2016.08.008. View

20.

Bolan G, Sparling P, Wasserheit J . The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012; 366(6):485-7. DOI: 10.1056/NEJMp1112456. View